✦ LIBER ✦

Weight- and Health-Related Quality of Life (WRQoL and HRQoL) with Canagliflozin (CANA) Versus Sitagliptin (SITA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Background Metformin

✍ Scribed by Traina, S.B.; Ho, K.F.

Book ID: 122318557
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 59 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.716

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth Mixture Modeling (GMM) to Determi

Growth Mixture Modeling (GMM) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (WRQoL) in Subjects with Type 2 Diabetes Mellitus (T2DM)

✍ Stull, D.E.; Houghton, K.; Traina, S.B. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Efficacy and Safety of Canagliflozin (CA

Efficacy and Safety of Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Metformin (MET) and Pioglitazone (PIO) Over 52 Weeks

✍ Goldenberg, Ronald; Forst, Thomas; Guthrie, Robert; Yee, Jacqueline; Vijapurkar, 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 132 KB

Sources of Long-Term Quality Adjusted Li

Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

✍ Willis, M.; Johansen, P.; Schroeder, M.; Thompson, G.; Girod, I.; Neslusan, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Clinical Characteristics, Quality Measur

Clinical Characteristics, Quality Measure Attainment, And Diabetes-Related Health Care Costs In Elderly Versus Overall People Living With Type-2 Diabetes Mellitus (T2dm) Receiving Metformin (Met) And Sulfonylurea (Su)

✍ Lafeuille, M.H.; Gravel, J.; Bailey, R.A.; Martin, S.; Garber, L.; Duh, MS; Lefe 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB